Section 4 of Chapter 52 of the Acts of 2016, An Act relative to substance use, treatment, education and prevention, amends section 13 of chapter 17 of the General Laws to require the Drug Formulary Commission, by September 1, 2016, to publish, distribute, and update annually a list of FDA approved, non-opioid drug products that are effective paindrug products  management alternatives and have a lesser potential for abuse than Schedule II and III opioid drug products.

This information is provided by the Drug Control Program within the Department of Public Health.